Mountcastle David sold $589K of PRVA
Mountcastle David (EVP & Chief Financial Officer) sold 21,275 shares of Privia Health Group, Inc. (PRVA) at $27.67 ($0.59M total) on 2026-07-09 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale size, price ($27.6700), and post-transaction holdings (164,853 shares), but it does not include any new corporate event or guidance.
Market read
Traders may note the insider sale for positioning, but the planned nature and lack of fundamental updates make it low signal.
What to watch
The disclosure does not indicate whether additional sales occurred under the same plan, nor does it reveal tax or diversification motives.
Background
The article is a SEC Form 4 insider transaction for Privia Health Group, Inc., reported by the CFO.
Ticker impact
Privia Health Group CFO David Mountcastle sold 21,275 shares in an open-market transaction for about $588.7K under a 10b5-1 plan.
Low likelihood of a sustained price move; any reaction should be muted and short-lived.
The filing is a Form 4 insider transaction, explicitly tied to a pre-arranged 10b5-1 plan, and provides no new company fundamentals or guidance.
Market effects
No clear read-across to healthcare services or managed care; this is company-specific insider trading.
None indicated.
None indicated.
Counterpoint
Even planned 10b5-1 sales can coincide with insider expectations of near-term risk, so traders may still watch for follow-on selling patterns.
Key entities
- issuerPrivia Health Group, Inc.
Subject of the Form 4 insider sale by its CFO under a 10b5-1 plan.
- insiderDavid Mountcastle
EVP and Chief Financial Officer who reported the open-market sale.